Plasma fibrinogen, ambulatory blood pressure, and silent cerebrovascular lesions: the Ohasama study

Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):963-8. doi: 10.1161/01.ATV.0000258947.17570.38. Epub 2007 Feb 1.

Abstract

Objective: Twenty-four-hour ambulatory blood pressure (24-hour ABP) values are considered a powerful predictor of stroke. Silent cerebrovascular lesions are associated with an increased risk of stroke. Because fibrinogen is a major determinant of plasma viscosity, an elevated fibrinogen level might also be associated with stroke risk. We evaluated the association of 24-hour ABP and plasma fibrinogen levels with the risk of silent cerebrovascular lesions (white matter hyperintensity and lacunar infarct) detected by MRI.

Methods and results: The study cohort comprised 958 individuals from the general population of Ohasama, a rural Japanese community. Multiple logistic regression analysis adjusted for age, sex, smoking and drinking status, use of antihypertensive medication, body mass index, 24-hour ABP, and a history of hypercholesterolemia, diabetes mellitus, and atrial fibrillation demonstrated that each 1-SD increase in fibrinogen level was associated with a significantly increased risk of silent cerebrovascular lesions (odds ratio, 1.26; P=0.001). The 24-hour ABP was also significantly and independently associated with the risk of silent cerebrovascular lesions. Even when 24-hour ABP values were within normal range (<135/80 mm Hg), elevated fibrinogen levels were associated with an increased risk of silent cerebrovascular lesions. Fibrinogen and 24-hour BP had additive effects on silent cerebrovascular lesions.

Conclusion: The 24-hour ABP and plasma fibrinogen levels were closely and independently associated with the risk of silent cerebrovascular lesions including white matter hyperintensity and lacunar infarct.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Blood Pressure Monitoring, Ambulatory*
  • Blood Pressure*
  • Cerebral Infarction / blood
  • Cerebral Infarction / diagnosis
  • Cerebral Infarction / physiopathology
  • Cerebrovascular Disorders / blood
  • Cerebrovascular Disorders / diagnosis
  • Cerebrovascular Disorders / etiology
  • Cerebrovascular Disorders / physiopathology*
  • Cohort Studies
  • Cross-Sectional Studies
  • Female
  • Fibrinogen / metabolism*
  • Humans
  • Logistic Models
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Risk Assessment

Substances

  • Fibrinogen